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A  unique human retrovirus (RV) 1 has been consistently isolated from patients 
with the acquired immune deficiency syndrome (AIDS).  Infection of human  T 
lymphocytes or T  lymphocyte lines with the AIDS RV can result in a  variety of 
outcomes ranging from rapid cell death to the integration of functionally inert 
proviral  DNAs  (1-3).  A  typical  AIDS  RV  infection  is  characterized  by  the 
appearance of multinucleated cells, a burst of reverse transcriptase (RT) activity, 
and  profound cellular degeneration  that  extends over a  5-20-d  period  (1,  4). 
Two  recent  reports  have  described  noncytotoxic effects of the  AIDS  RV  on 
human  lymphocytes. In one case (2),  PHA-stimulated,  IL-2-dependent cultures 
of helper-inducer human  T  cells exhibited the characteristic cytopathic effects 
of acute viral infection, but nonetheless, sufficient numbers of cells survived to 
continue to produce infectious virus during the 4  mo they were maintained  in 
culture. In the other (3), we described Leu-3- non-virus-producing ceils, derived 
from a  Leu-3 + T  cell line, that survived infection with the AIDS RV, and which 
could be induced with 5-iodo-2'-deoxyuridine (IUdR) to express infectious virus 
(3). 
In this report we have examined in greater detail IUdR induction of lympho- 
cytes surviving acute  viral  infection.  A  cellular clone was  isolated  from a  mass 
culture of survivor cells that contained a  single copy of the AIDS RV provirus. 
The integrated proviral DNA was constitutively expressed but generated defec- 
tive virus particles that failed to synthesize detectable reverse transcriptase. The 
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characterization  of the  survivor cell clone is presented,  and its potential  role in 
IUdR-mediated  induction  is discussed. 
Materials  and  Methods 
Viral In~ection, IUdR Induction,  and Cell Cloning.  ~2  ×  10  ~ A3.01  cells were infected 
with  a  10  dilution  of a  lymphadenopathy-associated  virus  (LAV)  stock  as  previously 
described (4).  After adsorption for  1 h  at  37°C, cells were washed and maintained  (10 6 
cells/ml) in RPMI  1640 medium supplemented with  10%  FCS. When the RT activity of 
the  Leu-3- cultures  that had  survived infection became undetectable  (7-10  d  after the 
peak of RT),  cells (10 6 cells/ml) were exposed to IUdR (100 ~g/ml) for 24 h, and then 
cocultivated with Leu-3  ÷ A3.01  cells, as previously described (3).  The induction of virus 
was heralded  by a  second wave of RT activity in the cocultured cells; when RT was no 
longer detectable,  the survivor cells were subjected to a second cycle of IUdR induction 
and  cocultivation.  The  RT-,  Leu-3-  cells  surviving  these  treatments  were  cloned  by 
limiting dilution in 96-well microtiter plates.  111 single cell clones were obtained, pooled 
into groups of 10, expanded to a total of 10  n cells, exposed to IUdR for 24 h, cocultivated 
with Leu-3  + A3.01 cells, and examined daily for expression of the AIDS RV by monitoring 
syncytia formation. A single clone (8E5) was obtained. 
Nucleic Acid Hybridization.  DNA and  RNA were prepared  from AIDS RV-infected 
cells or 8E5 cells, and analyzed for the presence of virus-related  sequences by Southern 
or Northern blot hybridization using cloned long terminal repeat (LTR) or representative 
gag-pol-env probes as previously outlined  (4-6).  For in situ hybridization,  cultured  cells 
were  sedimented  onto  polylysine-coated  glass  slides,  fixed  in  periodate/lysine/para- 
formaldehyde/glutaraldehyde (PLPG), and pretreated with HCI and proteinase K to allow 
the labeled probe to enter the cells (7-9).  Cells were prehybridized in  10 mM Tris pH 
7.4, 2x SSC (lx SSC is 0.15 M NaCI, 0.015 M sodium citrate, pH 7.4), 50% formamide, 
I x  Denhardt's solution (0.02% polyvinylpyrrolidone, 0.02% Ficoll, 0.02% BSA), and 200 
ug/ml yeast tRNA at 45°C for 2 h and hybridized in this solution containing 10% dextran 
sulfate, 5 #M DTT and 106 cpm of s5S-labeled AIDS RV RNA in 10-#1 reaction mixtures. 
Subgenomic  viral  DNA  fragments  present  in  pB1  (6),  pBenn6  (4),  pBll  (6),  and  a 
recombinant  plasmid  (pRG-B),  which  contains  a  1.35  kb  Hind  III fragment  mapping 
between  8.25  and  9.6  kb  on  the  proviral  DNA,  were  subcloned  into  SP6/T7  vectors 
(Promega Biotec,  Madison,  WI) and the  pooled DNAs were transcribed  using ssS-UTP 
(Amersham Corp.,  Arlington  Heights,  IL). The labeled  RNAs were incubated  with  40 
uM NaHCOs/60 #M NazCOs, pH  10.2, before hybridization to facilitate their entry into 
cells. 
Hybridization was performed at 45°C for 8 h. The samples were then washed twice in: 
2x SSC at 22°C for  I0 min; 2x SSC, 0.1%  Triton X-100 at 60°C for 30 min; 2x SSC 
with  RNase A  (40 ug/ml) and RNase Tj  (10 U/ml) at 37°C for 30 rain; and 2× SSC at 
60°C for 10 min. All solutions, excluding those with RNase, contained 5 #M DTT and  1 
#M EDTA. Autoradiography was performed for 1-2 d as previously described (8, 9). 
To control for the specificity of in situ  hybridization, probes synthesized in the sense 
orientation (same polarity as viral mRNA) were incubated with duplicate cell preparations; 
in addition,  uninfected cells were hybridized with antisense  probes (i.e.,  complementary 
to viral mRNA). Infected cell preparations were also treated with RNase before addition 
of the probe. 
Immunoblotting.  Total  cell  lysates prepared  from AIDS  RV-infected  A3.01  or  8E5 
cells (10 s) were electrophoresed through 3-27% gradient polyacrylamide gels (Integration 
Separation  Sciences,  Newton,  MA) by the  method  of Laemmli (10) and  transferred  to 
nitrocellulose membranes (11). The filters were then treated with 5% nonfat dry milk in 
10  mM  Tris  (pH  7.4)  and  155  mM  NaCI (TN) for 30  min,  and  further  rinsed  in TN 
buffer containing 0.3%  Tween-20,  0.5%  NP-40 (TN-TN), and  1%  BSA.  Pooled AIDS 
patients' sera, diluted (1:1,000) in TN-TN containing 3% BSA, were incubated with the 
nitro-cellulose filters overnight at room temperature.  The membranes were then washed 
three times in TN-TN buffer, incubated for 2 h with  ~2SI-protein A  (200,000 dpm/ml), 
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Electron  Microscopy.  A3.01  cells  infected  with  the  AIDS  RV,  or  8E5  cells,  were 
centrifuged at 650 g in standard Beem capsules.  The pellets were then gently washed in 
serum-free RPMI  1640 medium and fixed in situ for 1-2 h in 2.5% glutaraldehyde in the 
presence of 0.1  M sodium cacodylate buffer, pH 7.2. After three 5-rain washes in 0.1  M 
sodium cacodylate buffer containing 4% sucrose, the pellets were treated with 1% osmium 
tetroxide for  1-2  h.  They were then washed three times in  0.1  M sodium cacodytate 
buffer and  dehydrated  in  30-100%  ethanol,  followed by  a  final  dehydration  using 
propylene oxide.  The  samples  were  then  embedded  in  epon-Araldite  LX-112  (Ladd 
Research  Industries,  Inc.  Burlington, VT), and thin  sections were prepared.  After se- 
quential staining with lead acetate and urany] acetate, the preparations were examined in 
a  100B electron microscope at 80 kV (JEOL USA, Peabody, MA). 
Results 
We  have  previously  described  (4)  a  continuous  Leu-3  +  human  T  cell  line 
(A3.01) that is >95% susceptible to infection with the AIDS RV. After infection, 
a  majority of the A3.01  cells is killed; Leu-3- survivor cells emerge that can be 
induced with IUdR to synthesize infectious virions (3). At least two discrete non- 
virus-producing cells survive infection with the AIDS RV: most cells are sponta- 
neous Leu-3- revertants that arise despite repeated subcloning of the uninfected 
parental  I_,eu-3 + A3.01  cell line, and contain no proviral DNA (4); others (0.1- 
1% of the survivor cells) harbor inducible virus (3). 
Isolation of a Survivor Cell Clone Containing AIDS RV DNA.  Definitive biologic 
and  biochemical evaluation  of IUdR-mediated  virus  induction  clearly requires 
the cloning of the few cells containing the AIDS RV provirus that survive acute 
infection.  Although  the  assay  system  used  to  detect  induced  viral  particles  is 
quite sensitive (3), it is not readily applicable to a  cell cloning project in  which 
the desired  cell occurs at a  frequency of <10 -2.  In a  typical assay (3), survivor 
cells are  treated  with  IUdR,  and  because  they are  Leu-3-  and  therefore not 
susceptible  to  infection  with  the  AIDS  RV,  must  be  cocultured  with  Leu-3  + 
A3.01  cells, which adsorb and efficiently replicate the virus.  Induced virus can 
be monitored by assaying for RT activity 5-10 d after induction.  In view of the 
logistic demands attending the screening of several hundred survivor cell clones 
for the few that harbor inducible virus, several modifications were incorporated 
into the assay and selection system. 
A3.01  cells were infected with the LAV strain of the AIDS RV at a multiplicity 
of infection that resulted in a peak of RT activity on day 10.7 d  later, when RT 
activity was  no longer detectable,  ~2  x  106  of the  Leu-3- survivor cells were 
treated with  IUdR  and  cocultured with susceptible A3.01  to induce the AIDS 
RV.  The  cells  surviving  the  initial  induction  and  coculture  procedure  were 
subjected  to a  second cycle of IUdR  treatment  and  A3.01  cocultivation in  an 
attempt to increase the proportion of inducible cells.  Surviving cells, after this 
second induction and cocultivation procedure, became RT- on day 8 after IUdR 
treatment, and were then cloned by limiting dilution.  111  clones derived from 
the surviving mass culture were pooled in groups of 10, treated with IUdR, and 
cocultivated with A3.01  cells. Virus induction was monitored daily by screening 
the cocultures for syncytia formation.  We  elected to follow the appearance  of 
syncytia  by  light  microscopy  rather  than  RT  assays,  since  the  former  was 
logistically more suitable for the rapid  identification of the rare cell harboring 
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A single clone (8E5) was isolated that produced syncytia in cocultured Leu-3 + 
A3.01  cells  after  exposure  to  IUdR.  When  8E5  cells  were  expanded  and 
characterized  in  greater  detail,  an  unanticipated  result  was  obtained;  despite 
repeated treatments  with IUdR, no RT activity could be detected in the cocul- 
tures of 8E5 and the Leu-3 + A3.01  cells that  were maintained  for >30 d.  This 
was puzzling  in  view of the  readily demonstrable  syncytia that  appeared  24 h 
after IUdR treatment of the 8E5 cells. 
Detection  of Viral RNA,  DNA,  and Protein in 8E5 Cells.  Since it was unclear 
which,  if any,  AIDS  RV gene  products were being expressed in  induced  8E5 
cells, we used in situ hybridization to monitor the IUdR effect. As shown in Fig. 
1 A, virtually all of the IUdR-treated 8E5 cells synthesized viral RNA. Of interest 
was the fact that 8E5 cells, growing in the absence of IUdR, also expressed high 
levels of AIDS  RV RNA (Fig.  1B).  The  in situ  hybridization  results shown in 
Fig.  1 also indicated  that  cloned  8E5  cells contained  amounts  of viral  mRNA 
comparable to present those in a cell infected with virus (Fig.  1 C). To more fully 
evaluate the RNA present in the  8E5 clone, polyadenylated RNA was isolated 
and examined by Northern blot hybridization using an LTR probe as previously 
described (5).  Fig. 2B shows that, similar to A3.01 cells, which actively produce 
virus, uninduced 8E5 cells also contain substantial amounts of 9.1 (genomic/gag- 
pol), 5.0, 4.3 (env), and  1.8-2.0 kb viral RNAs. Although this Northern analysis 
suggested  that  the  expression  of the  5.5-kb  species  of viral  RNA  might  be 
reduced in  8E5 cells, S1  nuclease protection experiments  (S.  Venkatesan,  data 
not shown) indicated that RNAs processed at the putative splice acceptor for 5.5 
kb viral RNA were readily identified. 
The number and state of proviral DNA copies of 8E5 cells were analyzed by 
Southern blot hybridization of Eco RI-digested cellular DNA. Since the parental 
LAV provirus contains  two internal  Eco  RI  restriction  sites defining a  1.1  kb 
viral DNA segment, the presence of only three reactive cleavage products (Fig. 
2A) is consistent with the clonality of the 8E5 line and the existence of a single 
integrated copy of viral DNA. 
The results presented thus far clearly indicate that the one copy of the LAV 
provirus in 8E5 cells is constitutively expressed as viral RNA, but they provide 
no explanation  for the absence of RT activity after IUdR treatment.  As a  first 
step to address this question, the viral proteins present in 8E5 cells were analyzed 
by  immunoblotting  using  pooled  AIDS  sera,  as  described  in  Materials  and 
Methods.  A  side-by-side comparison  with the immunoreactive peptides present 
in virus-producing A3.01  cells (Fig. 2 C) revealed the presence of virus-encoded 
gp120, p55, p41, and p25 proteins and the absence of the prominent 64 kD and 
fainter 34 kD viral polypeptides in 8E5 cells. The immunoblot of the 8E5 clone 
also suggested the presence of a  reactive  50  kD band,  perhaps  representing  a 
truncated form of the 64 kD polypeptide identified in productively infected cells. 
A  similar  immunoblot  was  obtained  when  a  lysate,  prepared  from  8E5  cells 
treated with IUdR, was examined (data not shown). 
Characterization of Virus Particles Synthesized in 8E5 Cells.  Although the anal- 
ysis of the  cell  lysates  indicated  that  most  of the  major  AIDS  RV  structural 
proteins  were  synthesized  in  8E5  cells,  we  did  not  know  whether  they  were 
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FIGURE  1.  In situ hybridization of human T  lymphocyte lines synthesizing AIDS RV RNA. 
Photomicrographs of: 8E5 cells after (A) and before (B) treatment with IUdR; A3.01  cells 3 d 
after infection (C) with the AIDS RV; uninfected A3.01  cells (D); IUdR-inducible cells before 
(E) or after (F) incubation with IUdR. Original magnification, x  400. FOLKS  ET  AL.  285 
FIGURE 2.  Characterization of AIDS RV DNA, RNA, and proteins in 8E5 cells (A). 5.0 t~g 
of 8E5  DNA were digested with Eco RI and analyzed by Southern  blot hybridization using 
the pBenn6 (4) probe. (B) Polyadenylated RNA was prepared from virus-infected A3.01 (lane 
1)  or  8E5  (lane  2)  cells and  subjected  to  Northern  analysis  using  a  viral  LTR  probe  as 
previously described  (5).  (C)  Immunoblots of infected  A3.01  (lane  1)  or  8E5  (lane  2)  cell 
lysates carried out as described in Materials and Methods. 
microscope,  innumerable  RV-like  structures  were  seen  budding  from  their 
surfaces (Fig.  3).  These particles could be readily distinguished  from infectious 
virions produced in A3.01  cells because they lacked the condensed rod-shaped 
nuc]eoid characteristic of the AIDS RV. 
The tissue culture medium from untreated or IUdR-treated 8E5 cells was also 
examined  for the  presence  of infectious  virus particles.  Supernatants,  concen- 
trated  from  108 8E5  cells, were incubated with 2  ×  106  Leu-3  + A3.01  cells, as 
previously described (4),  in an attempt to amplify any released viral particles. In 
repeated experiments,  the synthesis of infectious progeny virions, as monitored 
by  RT  assays,  was  invariably  negative.  Nonetheless,  A3.01  cells  exposed  to 
concentrated  8E5  tissue culture  supernatants  did exhibit minimal  syncytia for- 
mation.  However,  the  development  of syncytia could  not  be shown  after  the 
serial (and blind) passage of the 8E5 supernatant  through A3.01  cells. 
In Situ Hybridization of lUdR-inducible Cells.  Since the characterization  of the 
cloned 8E5 survivor cell indicated the presence of a single copy of proviral DNA 
that  directed the synthesis of defective virus particles,  we wished to determine 
how  and  when  this  cell  arose.  Accordingly,  we  used  in  situ  hybridization  to 
evaluate the  IUdR-inducible cells that  survived the initial  infection  with  LAV. 
As shown in  Fig.  1 E, cells constitutively expressing AIDS RV mRNA could be 
identified in the mass culture of IUdR-inducible cells existing at a frequency of 
_> 1/1,000  at  least two I UdR-induction/cocultivation  cycles before the isolation FIGURE 3.  AIDS  RV particles synthesized from  8E5  (A) or virus-infected A3.01  (B) cells. 
Original magnification, x  50,000. 
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of the 8E5 clone.  In the presence of IUdR, the level of viral  RNA synthesis in 
the survivor cells did not appreciably change (Fig.  1 F). 
Discussion 
The results presented here describe the isolation of a cellular clone (8E5) that 
harbors an  integrated  defective AIDS  RV genome.  The clone is derived from 
an IUdR-induced mass culture that has survived AIDS RV infection. 
I UdR and other halogenated pyrimidines are known inducers of RVs (12-14). 
Although  their  precise  mechanism  of action  is  unknown,  it  has  been assumed 
that these chemicals act on functionally inactive but structurally intact integrated 
copies of proviral  DNA.  It  has  been  proposed  (15),  for  example,  that  IUdR 
modulates transcription  of integrated viral  DNA, resulting in increased expres- 
sion  of  dormant  proviruses,  "and  ultimately  to  the  appearance  of infectious 
retroviral  particles.  IUdR also has the potential  for producing other effects in 
eukaryotic  cells,  such  as  unscheduled  DNA  replication,  recombination,  and 
mutagenesis. 
We previously reported (3) that IUdR treatment of virus-free, Leu-3- lympho- 
cytes surviving infection with the AIDS RV induced infectious virus, as monitored 
by RT assays. The  IUdR-induced progeny virions were indistinguishable  from 
their  LAV parent  in  terms  of tropism  for  Leu-3 + lymphocytes, the cytopathic 
effect that  occurred  during  their  replication  in  human  T  cells,  and  in  their 
kinetics of infection. We had expected to clone an IUdR-inducible survivor cell 
that contained a wild-type provirus, and were therefore surprised when it became 
apparent  that  8E5  cells  harbored  a  defective  copy of the  viral  DNA.  It  was 
unclear whether the 8E5 clone was an artifact of viral infection, IUdR treatment, 
the cloning procedure,  or whether  it was a  biologically relevant  participant  in 
the induction of infectious virus. 
In a previous examination of IUdR inducibility (3), we noted that no virus was 
detected when ~< 100 virus-free survivor cells were evaluated; virus was obtained 
when  ~i,000  cells  were  exposed  to  the  haiogenated  pyrimidine.  This  result 
implied that between 0.1 and  1% of the cells surviving the initial  LAV infection 
could be induced  to express virus.  In situ  hybridization  analyses of the  IUdR- 
inducible  cells indicated  that  a  similar  fraction  also contained  a  provirus  that 
synthesized AIDS  RV mRNA in  the presence or absence of IUdR.  Thus,  the 
mass culture of cells surviving infection clearly harbors a subpopulation, indistin- 
guishable from the 8E5 clone, that constitutively expresses viral RNA. 
Assuming  that  a  copy of proviral  DNA,  similar  to that  present  in  8E5  ceils, 
somehow participates  in  IUdR induction  of virus, and is not an artifact of the 
cloning procedure or IUdR-mediated mutagenesis, a  model could be proposed 
explaining  the  origin  of the  defective provirus and  this  form  of viral  latency. 
The  single  mutated  copy of AIDS  RV proviral  DNA  in  8E5  cells very likely 
represents a reverse transcript  of a defective virion present in the original  LAV 
inoculum.  In this regard,  we have encountered  AIDS RV proviruses in prepa- 
rations  of infected cellular  DNA  that  contain  small  deletions or inappropriate 
termination codons that would preclude their expression as infectious virus (our 
unpublished  observations).  Thus  it  would  be  necessary for an  8E5-1ike  virus, 
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then  integrate  a  DNA copy of its genome into the chromosome of an infected 
human  lymphocyte.  This  could  be  accomplished  if the  RT  activity  required 
during  the  initial  phase of a  hypothetical  8E5 viral  infection could be supplied 
by: (a) simultaneous infection with a replication-competent AIDS RV, or (b) the 
pseudotyping of the 8E5 virus with wild-type RT, since RT is a virion structural 
protein. 
At present, we have no explanation of IUdR induction in the AIDS RV system. 
Clearly, the 8E5 clone cannot be induced to yield infectious virus after exposure 
to IUdR. However, it is tempting to speculate that cells harboring a single copy 
or multiple defective copies of viral  DNA exist within  the survivor population. 
The mass culture of survivor cells might therefore contain a spectrum of mutated 
proviral DNAs, no one of which could encode infectious virus.  However, when 
exposed to an external stimulus such as IUdR, individual members of the survivor 
cell population  might  be induced to express larger amounts of AIDS RV RNA 
which,  following  complementation  and/or  recombination,  could  give  rise  to 
infectious virus.  To test such a  possibility, we are presently isolating additional 
independent  clones from the mass culture that have survived an initial  cycle of 
infection. 
Studies are also in progress to map the defect in the 8E5 provirus. The results 
of immunoblotting and Northern  hybridization analyses indicate that the LTR, 
gag,  and env regions of the proviral  DNA are functionally intact.  The integrity 
of the trans-activating segments (16) of the integrated  8E5 provirus was shown 
by transfecting  8E5  ceils and  a  Leu-3-  spontaneous  revertant  of the  parental 
A3.01  line  (designated  A2.01  [3])  with  a  chloramphenicol  acetyl  transferase 
(CAT) construction  under the control of an AIDS RV LTR. Striking enhance- 
ment  of CAT  activity  was  detected  in  8E5  (A.  Adachi  and  M.  A.  Martin, 
unpublished  data),  but  not  in  A2.01  cells,  indicating  that  the  trans-activating 
regions  of the  integrated  8E5  provirus  were  being  actively  expressed.  The 
absence  of the  immunoreactive  p64  and  p34  viral  proteins,  coupled  with  the 
appearance of defective virus particles unable to synthesize RT, suggest a defect 
in  the pol  gene.  The  location  of mutation(s)  within  the  8E5  proviral  DNA  is 
currently being evaluated by marker  rescue and  nucleotide sequencing  proce- 
dures. 
Although  8E5  cells cannot  be directly  used  to  study  IUdR  induction,  they 
might  be used in cocultures with other clones of survivor cells, also containing 
defective proviruses, as a  model system. 8E5 cells, nonetheless, express most of 
the  AIDS  RV-encoded  proteins  and  thereby  represent  a  potentially  useful 
reagent.  For example,  the development of syncytia attending  the cocultivation 
of 8E5 and parental  A3.01  cells suggests that biologically active viral envelope 
proteins are synthesized. These viral proteins could be used to develop diagnostic 
reagents,  therefore  obviating  potential  biohazards  attending  the  isolation  of 
analogous proteins from cells producing infectious virus. Since it contains a single 
copy  of  viral  DNA,  8E5  cells  may  also  prove  to  be  extremely  valuable  in 
delineating  the  immune  response to  virus-encoded proteins.  For instance,  the 
use  of 8E5  cells  as  targets  for  MHC-compatible  cytotoxic  lymphocytes could 
provide important  new insights regarding the mechanisms of immune-mediated 
elimination of virus-infected cells. FOLKS  ET  AL.  289 
The presence of the 8E5 proviral DNA and the synthesis of all viral proteins 
except p64  have  no  effect on  cell  viability.  Thus,  if a  virus-encoded protein, 
rather  than  the  complex  process  of virus  replication,  is  responsible  for  viral 
cytopathic effects and cell death,  such a  protein is not synthesized in  8E5 cells 
and could certainly be identified during detailed evaluations of the cloned line. 
Summary 
Leu-3- cells that survive infection with the acquired immune deficiency syn- 
drome (AIDS) retrovirus can be induced with  IUdR to express infectious virus 
(1).  A  cellular  clone  (8E5),  isolated  by  limiting  dilution  of a  mass  culture  of 
survivor  cells,  was  found  to  contain  a  single,  integrated  provirus  that  was 
constitutively expressed. Although IUdR treatment of 8E5 cells failed to induce 
infectious  virus,  cocultivation  with  Leu-3 +  cells  generated  the  characteristic 
syncytia associated  with acute AIDS retrovirus infection. The single integrated 
copy of proviral DNA directs the synthesis of all major viral structural proteins 
except p64, as monitored by immunoblotting. The relationship of the 8E5 clone 
to viral latency and persistence is discussed. 
Received for publication  3 February 1986 and in revised form 31 March 1986. 
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